Grafa News and Videos — Page 317

Telix (NASDAQ:TLX) received U.S. Food and Drug Administration approval for Pixclara, or floretyrosine F 18, as a PET imaging drug for evaluating glioma.

Hub Group (NASDAQ:HUBG) released preliminary unaudited first-half 2026 results, warning investors that the company expects to report an operating loss before one-time charges due to increased operating pressures and accounting-related expenses.

Surf Air Mobility (NYSE:SRFM) said subsidiary Mokulele Airlines secured a four-year U.S. Department of Transportation Essential Air Service contract valued at $19.4 million to continue serving Lanaʻi, Hawaiʻi.

Coda Octopus Group (NASDAQ:CODA) reported fiscal third-quarter 2026 revenue of $7.7 million for the period ended July 31, 2026, representing a 9.2% increase compared with the same period last year.

Brookfield Asset Management (NYSE:BAM) and American Real Estate Partners (AREP) announced that affiliates of Brookfield have agreed to acquire a minority interest in AREP.

Hain Celestial (NASDAQ:HAIN) reported fiscal fourth-quarter and full-year 2026 results showing improved cash generation and lower leverage despite declining sales.

Hain Celestial (NASDAQ:HAIN) agreed to sell the majority of its International business to private equity firm AURELIUS for approximately $323 million in cash as part of its strategic transformation plan.

Radiopharm Theranostics (NASDAQ:RADX) reported that RAD101 PET achieved 93% concordance with MRI across all evaluable lesions in an interim Phase 2b analysis, meeting the imaging trial’s primary endpoint.

Perspective Therapeutics entered a clinical trial collaboration and supply agreement with Merck (NYSE:MRK) to evaluate targeted alpha therapy PSV359 in combination with Keytruda in FAP-α-positive solid tumors.

WisdomTree (NYSE:WT) reported record assets under management of approximately $174 billion globally at the end of August 2026, supported by strong client demand and continued inflows across its investment products.